1.	Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 45 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20050209, ABCSG-18, 2005-005275-15, NCT00556374
2.	A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy Phase: Phase III Type: Supportive care Status: Active Age: 30 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20080560, NCT00925600
3.	Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20090482, NCT01345019
4.	Study of AMG 162 in Subjects with Advanced Cancer Currently Being Treated with Intravenous (IV) Bisphosphonates Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20040114, UCLA-0501073-01, AMGEN-20040114, NCT00104650
5.	Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UCSF Protocol No. 117527, NCT01545648
6.	Anakinra or Denosumab and Everolimus in Advanced Cancer Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-1043, NCT01624766